Linked Life Data

18068196

Source:http://linkedlifedata.com/resource/pubmed/id/18068196

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18068196rdf:typepubmed:Citationlld:pubmed
pubmed-article:18068196lifeskim:mentionsumls-concept:C0021368lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0151744lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0076726lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0600519lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0035124lld:lifeskim
pubmed-article:18068196lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:18068196pubmed:issue3-4lld:pubmed
pubmed-article:18068196pubmed:dateCreated2008-1-8lld:pubmed
pubmed-article:18068196pubmed:abstractTextWe assessed the role of nitric oxide (NO) and the kinin B2 receptor in mediating tissue kallikrein's actions in intramyocardial inflammation and cardiac remodeling after ischemia/reperfusion (I/R) injury. Adenovirus carrying the human tissue kallikrein gene was delivered locally into rat hearts 4 days prior to 30-minute ischemia followed by 24-hour or 7-day reperfusion with or without administration of icatibant, a kinin B2 receptor antagonist, or N(omega)-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor. Kallikrein gene delivery improved cardiac contractility and diastolic function, reduced infarct size at 1 day after I/R without affecting mean arterial pressure. Kallikrein treatment reduced macrophage/monocyte and neutrophil accumulation in the infarcted myocardium in association with reduced intercellular adhesion molecule-1 levels. Kallikrein increased cardiac endothelial nitric oxide synthase phosphorylation and NO levels and decreased superoxide formation, TGF-beta1 levels and Smad2 phosphorylation. Furthermore, kallikrein reduced I/R-induced JNK, p38MAPK, IkappaB-alpha phosphorylation and nuclear NF-kappaB activation. In addition, kallikrein improved cardiac performance, reduced infarct size and prevented ventricular wall thinning at 7 days after I/R. The effects of kallikrein on cardiac function, inflammation and signaling mediators were all blocked by icatibant and L-NAME. These results indicate that tissue kallikrein through kinin B2 receptor and NO formation improves cardiac function, prevents inflammation and limits left ventricular remodeling after myocardial I/R by suppression of oxidative stress, TGF-beta1/Smad2 and JNK/p38MAPK signaling pathways and NF-kappaB activation.lld:pubmed
pubmed-article:18068196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:languageenglld:pubmed
pubmed-article:18068196pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:citationSubsetIMlld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18068196pubmed:statusMEDLINElld:pubmed
pubmed-article:18068196pubmed:monthJanlld:pubmed
pubmed-article:18068196pubmed:issn0024-3205lld:pubmed
pubmed-article:18068196pubmed:authorpubmed-author:ChaoJulieJlld:pubmed
pubmed-article:18068196pubmed:authorpubmed-author:ChaoLeeLlld:pubmed
pubmed-article:18068196pubmed:authorpubmed-author:YinHangHlld:pubmed
pubmed-article:18068196pubmed:issnTypePrintlld:pubmed
pubmed-article:18068196pubmed:day16lld:pubmed
pubmed-article:18068196pubmed:volume82lld:pubmed
pubmed-article:18068196pubmed:ownerNLMlld:pubmed
pubmed-article:18068196pubmed:authorsCompleteYlld:pubmed
pubmed-article:18068196pubmed:pagination156-65lld:pubmed
pubmed-article:18068196pubmed:dateRevised2011-6-1lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:meshHeadingpubmed-meshheading:18068196...lld:pubmed
pubmed-article:18068196pubmed:year2008lld:pubmed
More...